Meet ChemPartner at AACR Annual Meeting 2016
ChemPartner will attend the AACR Annual Meeting on April 16-20 at Ernest N. Morial Convention Centerin in New Orleans. AACR is a must-attend event for cancer researchers and the broader cancer community, with “Delivering Cures Through Cancer Science” as this year’s theme. There will be a number of presentations that include exciting new data from cutting-edge clinical trials as well as companion presentations that spotlight the science behind the trials and implications for delivering improved care to patients.
There are several ways that you can connect with us:
Meet with us at our booth (#240)
- Meet with us at our poster which highlights some of the great work we have done lately Poster: #4929. Wednesday Apr 20, 8:00 AM – 12:00 PM.
By booking an appointment with us
- Contact Dr. Robert Drakas, Senior Director Business Development, US East (email@example.com; 1-215-720-6650)
- Contact Dr Sarah Lively, Senior Director Business Development and Head of Operations ChemPartner, San Francisco (firstname.lastname@example.org; 1-650-830-1761)
ChemPartner is a science driven, technology based, high quality global CRO partner servicing 400+ global biopharmaceutical companies since 2002. ChemPartner’s extensive expertise in Oncology drug R&D includes Chemistry, Biologics and Biology utilizing 300+ enzymatic/receptor assays, 700+ cancer cell lines, 300+ tumor models, molecular pathology and bioanalytics.
ShangPharma is the parent company of ChemPartner, ShangPharma Technologies, and ShangPharma Investments. Through all its divisions, ShangPharma aims to create an ecosystem that allows close interaction between major hospitals and academic centers, by matching them with pharma, biotech, and research institutes it can enable the success of all. The group is actively investing, licensing, and forming partnerships to better serve the healthcare industry. Meet with us to find out more.
More details about ChemPartner, please find at: www.chempartner.com